Ahsan Rizwan

Ahsan Rizwan is a seasoned professional in clinical pharmacology with extensive experience across various esteemed organizations. Currently serving as Senior Director of Clinical Pharmacology at BeiGene since December 2019, Ahsan Rizwan has been instrumental in managing clinical pharmacology for immuno-oncology drug development at Nektar Therapeutics and played key roles at Astellas Pharma and Quintiles Inc. Ahsan Rizwan's academic qualifications include a PhD in Molecular Biology from the University of Göttingen and a GSK-Clinical Pharmacokinetics Fellowship from the University of North Carolina at Chapel Hill, complemented by a Master's in Pharmacy from Jamia Hamdard University. Additional leadership experience includes directing sponsorship and corporate relations for the National Association of Asian American Professionals – Greater Kansas City.